The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 23 of the 50 sources its claims cite were checked for support.
Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial
Open accessAbstract
Background and aim Primarily, this study compares the efficacy of probiotic and acceptance and commitment therapy (ACT) in alleviating the severity of alcohol craving and alcohol use disorder (AUD) among patients who had undergo two weeks of in-patient detoxification. Secondarily, this study compares the efficacy of probiotic and ACT in mitigating the severity of comorbid depression and anxiety symptoms; decreasing serum level of pro-inflammatory cytokines, such as interleukin 1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α (TNF-α); changing the event-related potential in electroencephalogram (EEG) and restoring microbiota flora in the gut of AUD patients. Methods and analysis Initially, during Phase I of the study, the serum level of IL-1β, IL-6 and TNF-α; ERP changes in the EEG and fecal microbiota content will be compared between 120 AUD patients and 120 healthy controls. Subsequently in Phase II of the study, 120 AUD patients will be randomized by stratified permuted block randomization into the probiotic, ACT and placebo groups in a 1:1:1 ratio. Participants in the probiotic and placebo groups will be administered one sachet per day of Lactobacillus spp. probiotic and placebo, respectively for 12 weeks. While those in the ACT group will receive one session per week of ACT for 8 weeks. Outcome measures will be administered at four timepoints, such as t0 = baseline assessment prior to intervention, t1 = 8 weeks after intervention began, t2 = 12 weeks after intervention and t3 = 24 weeks after intervention. Primary outcomes are the degrees of alcohol craving, alcohol withdrawal during abstinence and AUD. Secondary outcomes to be assessed are the severity of co-morbid depression and anxiety symptoms; the serum levels of IL-1β, IL-6 and TNF-α; changes in ERP and fecal microbiota content. © 2023 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Overview
CoChat Summary
TL;DR
This is a 2023 trial protocol, not results, for a two-phase study testing whether Lactobacillus probiotics or acceptance and commitment therapy (ACT) reduce alcohol craving and alcohol use disorder (AUD) severity after 2 weeks of inpatient detoxification. Phase II will randomize 120 male AUD patients to probiotic, ACT, or placebo and follow them at 0, 8, 12, and 24 weeks.
Key findings
- Not stated in the paper.
- The protocol’s primary aim is to compare probiotic and ACT effects on alcohol craving, alcohol withdrawal, and AUD severity at four timepoints: baseline, 8 weeks, 12 weeks, and 24 weeks.
- Secondary outcomes include depression/anxiety, serum IL-1β, IL-6, and TNF-α, ERP/EEG changes, and fecal microbiota content.
- The planned sample sizes are 120 per group in Phase I (120 AUD patients and 120 healthy controls; effect size 0.4, α = 0.05, power = 0.8) and 120 total in Phase II (40 per group; effect size 0.15, α = 0.05, power = 0.8), with dropout rates of 20% and 30%, respectively.
Methods
- Phase I is a case-control study comparing 120 AUD patients with 120 healthy controls, matched on age, gender, and ethnicity; Phase II is a single-blind, three-armed, parallel-group, multicenter randomized controlled trial.
- Phase II randomizes 120 male AUD patients after 2 weeks of inpatient detoxification into Lactobacillus spp. probiotic, ACT, or placebo in a 1:1:1 ratio using stratified permuted block randomization by age.
- Outcomes are analyzed with independent t-tests or Mann-Whitney U tests in Phase I; in Phase II, one-way ANOVA/Kruskal-Wallis at each timepoint and mixed ANOVA or nonparametric mixed-effect ANOVA across time, with intention-to-treat analysis and p < 0.05.
Limitations
- The paper states that the sample will be limited to Chinese Han men in China and Malaysian Chinese Han men, so findings may not generalize to the broader AUD population.
- The paper states that it includes only male patients, limiting generalizability to women; this is especially evident because no female participants are included.
- Because this is a protocol, no efficacy or safety results are reported yet, which is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
15 Valid · 5 Not valid · 23 Not checked · 26 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Similarly, the efficacy of naltrexone and acamprosate are also suspected and inconclusive for preventing relapse in AUD [55].”
§ Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial > Discussion
What the sources say
- Disputedcites [55] EM Burnette, 2022, Novel agents for the pharmacological treatment of alcohol use disorder, Drugs sourceExperimental — accuracy not yet measured
The Approved Agents section acknowledges some negative trials and mixed results, but it also reports that meta-analyses found acamprosate reduced return to any drinking and naltrexone reduced return to any drinking and binge drinking. It describes naltrexone’s effects as modest, not as having inconclusive efficacy overall. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In addition, several clinical studies reported that probiotics have a role in modulating mood and social functioning [26].”
§ Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial > Introduction > Relationship between intestinal microbiota, probiotic, and alcohol dependence Over the past decade, the link between the gut, and specifically the gut microbiome, and alcohol dependence has come to the attention of researchers. In individuals with alcohol addiction, drinking can disrupt intestinal barrier function, also known as intestinal leakage [11, 12]. The intestinal barrier consists of intestinal cells, goblet cells, and antibacterial substances that influence the intestinal microbiota within the mucus layer, as well as many immune cells in the lamina propria [13]. The mechanism by which alcohol or its metabolites cause intestinal leakage is unknown, and may be related to intestinal disorders, immune system activation, and inflammation. Persistent alcohol abuse can change fecal pH, promote excessive growth of pathogens, and alter the function of intestinal microorganisms by altering the secretion of specific metabolites involved in intestinal barrier dysfunction [14, 15]. Elevated levels of plasma cytokines such as TNF α, interleukin and CRP in patients with AUD suggest chronic, low-grade, systemic inflammation [16]. One possible mechanism of systemic inflammation and alcohol addiction is that intestinal bacterial products activate peripheral blood monocytes and induce cytokines to enter the blood, leading to alcohol addiction and other psychiatric disorders, including major depressive disorder, bipolar disorder and anxiety disorder [17]. Alcohol cravings and negative emotions such as anxiety and depression were highly associated with alcohol-seeking behavior and relapse, suggesting that reducing systemic inflammation may improve mental health and prevent relapse [17].
What the sources say
- Could not verifycites [26] S Leclercq, 2020, Gut microbiota-induced changes in β-hydroxybutyrate metabolism are linked to altered sociability and depression in alcohol use disorder, Cell Rep sourceExperimental — accuracy not yet measured
The Discussion links gut microbiota with sociability and depression-related behavior, but does not report clinical studies of probiotics modulating mood or social functioning. A search for “probiotics” found only an exclusion criterion in Experimental Model and Subject Details: participants who had recently taken probiotics were excluded. The paper’s findings about gut microbiota and fecal microbiota transplantation do not establish the attributed claim about probiotics. (LLM, conf=0.76)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Therefore, psychological dependence is the key factor leading to people start drinking again after abstinence”
§ Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial > Introduction
What the sources say
- Could not verifycites [6] A Sachdeva, 2015, Alcohol withdrawal syndrome: benzodiazepines and beyond, J Clin Diagn Res sourceExperimental — accuracy not yet measured
The paper’s discussion of alcohol dependence describes withdrawal and impaired control over drinking, and its Alcohol Withdrawal Syndrome section describes symptoms after cessation. Neither addresses whether psychological dependence is the key reason people resume drinking after abstinence (searched: psychological dependence, relapse after abstinence). (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This suggests that the Rosell®-52 and Rosell®-175 interventions were able to alter functional connectivity in regions of the brain that are active and regulate emotional and stress responses.”
§ Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial > Introduction > Relationship between intestinal microbiota, probiotic, and alcohol dependence Over the past decade, the link between the gut, and specifically the gut microbiome, and alcohol dependence has come to the attention of researchers. In individuals with alcohol addiction, drinking can disrupt intestinal barrier function, also known as intestinal leakage [11, 12]. The intestinal barrier consists of intestinal cells, goblet cells, and antibacterial substances that influence the intestinal microbiota within the mucus layer, as well as many immune cells in the lamina propria [13]. The mechanism by which alcohol or its metabolites cause intestinal leakage is unknown, and may be related to intestinal disorders, immune system activation, and inflammation. Persistent alcohol abuse can change fecal pH, promote excessive growth of pathogens, and alter the function of intestinal microorganisms by altering the secretion of specific metabolites involved in intestinal barrier dysfunction [14, 15]. Elevated levels of plasma cytokines such as TNF α, interleukin and CRP in patients with AUD suggest chronic, low-grade, systemic inflammation [16]. One possible mechanism of systemic inflammation and alcohol addiction is that intestinal bacterial products activate peripheral blood monocytes and induce cytokines to enter the blood, leading to alcohol addiction and other psychiatric disorders, including major depressive disorder, bipolar disorder and anxiety disorder [17]. Alcohol cravings and negative emotions such as anxiety and depression were highly associated with alcohol-seeking behavior and relapse, suggesting that reducing systemic inflammation may improve mental health and prevent relapse [17].
What the sources say
- Partly supportedcites [27] HMT Edebol Carlman, 2022, Probiotic mixture containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum affects brain responses to an arithmetic stress task in healthy subjects: A randomised clinical trial and proof-of-concept study, Nutrients sourceExperimental — accuracy not yet measured
The Abstract reports that the probiotic intervention altered functional connectivity in regions known to regulate emotion and stress responses. But the Study Intervention section describes one product containing R0052 and R0175 alongside a third strain, R1012; it does not establish an effect of the two named strains separately. (LLM, conf=0.87)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Therefore, the use of probiotics in the treatment of alcohol dependence and substance dependence may be a promising treatment [25].”
§ Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial > Introduction > Relationship between intestinal microbiota, probiotic, and alcohol dependence Over the past decade, the link between the gut, and specifically the gut microbiome, and alcohol dependence has come to the attention of researchers. In individuals with alcohol addiction, drinking can disrupt intestinal barrier function, also known as intestinal leakage [11, 12]. The intestinal barrier consists of intestinal cells, goblet cells, and antibacterial substances that influence the intestinal microbiota within the mucus layer, as well as many immune cells in the lamina propria [13]. The mechanism by which alcohol or its metabolites cause intestinal leakage is unknown, and may be related to intestinal disorders, immune system activation, and inflammation. Persistent alcohol abuse can change fecal pH, promote excessive growth of pathogens, and alter the function of intestinal microorganisms by altering the secretion of specific metabolites involved in intestinal barrier dysfunction [14, 15]. Elevated levels of plasma cytokines such as TNF α, interleukin and CRP in patients with AUD suggest chronic, low-grade, systemic inflammation [16]. One possible mechanism of systemic inflammation and alcohol addiction is that intestinal bacterial products activate peripheral blood monocytes and induce cytokines to enter the blood, leading to alcohol addiction and other psychiatric disorders, including major depressive disorder, bipolar disorder and anxiety disorder [17]. Alcohol cravings and negative emotions such as anxiety and depression were highly associated with alcohol-seeking behavior and relapse, suggesting that reducing systemic inflammation may improve mental health and prevent relapse [17].
What the sources say
- Partly supportedcites [25] V Vatsalya, 2023, The beneficial effects of lactobacillus gg therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis, Am J Gastroenterol sourceExperimental — accuracy not yet measured
The Discussion reports that Lactobacillus GG reduced heavy drinking in a six-month pilot study of patients with alcohol use disorder and moderate alcohol-associated hepatitis; the drinking-results section also reports a greater reduction than with placebo. This supports probiotics as a possible approach for alcohol use disorder in that population, but the paper does not study dependence on other substances. Page numbers are unavailable in our copy. (LLM, conf=0.88)
hedgedstates a possible causen = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
18 more claims · 5 with their cited sources checked
Create a free account to see all 69 claims and to verify the 4 references still open.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 30
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Acceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 1×
“ACT was designed to increase adaptive coping through acceptance, cognitive defusion, mindfulness, and perspective-taking exercises while supporting clients in aligning behavior with their personal values [31, 32].”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0442-1 · Cited by 2,747
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Bohn, M. J., Babor, T. F., & Kranzler, H. R. (1995) · Journal of Studies on Alcohol · doi:10.15288/jsa.1995.56.423 · Cited by 1,356
Noguchi, K., Gel, Y. R., Brunner, E., & Konietschke, F. (2012) · Journal of Statistical Software · doi:10.18637/jss.v050.i12 · Cited by 1,142
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044
Research works printed but not linked: 4
- H Deng, 2021, A review of EEG-based electrophysiological techniques for diagnosing and treating alcohol dependence, Chin J Drug Depend, 30, 92
- W. Hao, 2014, Guideline for diagnosis and treatment of alcohol-related disorders
- SC Hayes, 2005, Get out of your mind and into your life: The New Acceptance and Commitment Therapy.
- C Wang, 2011, Study on factor structure of Hamilton rating scale for anxiety, J Clin Psychiatry, 21, 299
Cited by
Shokr, M. M., Eladawy, R. M., Azar, Y. O., & Raish, S. M. A. (2025) · Foods · doi:10.3390/foods14172926 · Cited by 27
“These strains reduce pro-inflammatory cytokines like interleukin-6 (IL-6), interleukin-1 β (IL-1 β ), and tumor necrosis factor-alpha (TNF-α ), while promoting the production of anti-inflammatory cytokines such as interleukin-10 (IL-10) [156,197,198].”
InfluentialMafe, A. N., Nkene, I. H., Ali, A. B. M., Edo, G. I., Akpoghelie, P. O., Yousif, E. A., Isoje, E. F., Igbuku, U. A., Ismael, S. A., Essaghah, A. E. A., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10569-4 · Cited by 20
Alcohol-associated liver disease: Emerging therapeutic strategies
Mullish, B. H., & Thursz, M. R. (2024) · Hepatology · doi:10.1097/hep.0000000000000986 · Cited by 14
“[85] Currently, a small amountofsupportive datain this domain; for instance, in a study randomizing 46 patients with AUD and moderate alcohol and moderate AH to 6 mo of either oral LGG or placebo, average weekly intake of alcohol-associated drinks significantly reduced from baseline to 6 mo in the…”
Alexandrescu, L., Tofolean, I. T., Tofolean, D. E., Nicoara, A. D., Twakor, A. N., Rusu, E. E., Preotesoiu, I., Dumitru, E., Dumitru, A., Tocia, C., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13092000 · Cited by 8
“The remaining studies (Zhang et al. [35], Amadieu et al. [37], Muthiah et al. [39], Lang et al. [41], and Haas et al. [42]) did not provide sufficient outcome data to compute effect sizes.”
Gut microbiota and alcohol use disorder: a new frontier in treatment and recovery
Skryabin, V. Y. (2025) · BJPsych Bulletin · doi:10.1192/bjb.2025.10129 · Cited by 7
“For instance, Zhang et al 29 reported that Lactobacillus casei supplementation reduced serum zonulin (a marker of gut permeability) by 25% in a 12-week randomised controlled trial (RCT).”
Metadata
- Authors
- Zhang, B., Zhang, R., Deng, H., Cui, P., Li, C., Yang, F., & Leong Bin Abdullah, M. F. I.
- Affiliations
- Universiti Sains Malaysia (MY)
- Henan Psychiatric Hospital (CN)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-12-05
- Volume
- 18
- Issue
- 12
- Pages
- e0294768
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC10697511
- OpenAlex
- W4389332049
- Semantic Scholar
- 55491c674c55b0ba159c0639732ff1c9c01af041
- Cited by
- 6
- References
- 54
- Citations by year
- 2025: 5 · 2024: 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Second Affiliated Hospital Xinxiang Medical University (2022-xyefykfkt-003)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, alcoholism, acceptance and commitment therapy, alcohol craving, alcohol withdrawal, comorbid depression, anxiety comorbidity, inflammatory cytokines, IL-1β, interleukin-6, TNF-α, event-related potentials, gut microbiota, Lactobacillus, inpatient detoxification, adult male
- MeSH terms
- Adult, Alcoholism, Double-Blind Method, Humans, Male, Substance Withdrawal Syndrome, Tumor Necrosis Factor-alpha, Interleukin-6, Randomized Controlled Trials as Topic, Treatment Outcome, Clinical Trials, Phase II as Topic, Probiotics, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial. https://app.cochat.ai/papers/10.1371/journal.pone.0294768
- The paper
- Zhang, B., Zhang, R., Deng, H., Cui, P., Li, C., Yang, F., & Leong Bin Abdullah, M. F. I. (2023). Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0294768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.